Latham & Watkins represented MeiraGTx in the transaction. MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage gene therapy company, announced a financing agreement with affiliates...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here